PACAP Alleviates Paclitaxel‐Induced Peripheral Neuropathy by Targeting Oxidative Stress and Mitochondrial Damage via the PGC‐1α Pathway
CNS Neuroscience & Therapeutics · 2026-01 · 32 (1)
DOI: 10.1002/cns.70745 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 22.01.2026. Verfasst von Ruyue Mo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Paclitaxel, Oxidative Stress, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Pituitary Adenylate Cyclase-Activating Polypeptide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality, Shenzhen Nanshan District Healthcare System Science and Technology Key Projects.
Abstract (Originalsprache)
Background
Paclitaxel‐induced peripheral neuropathy (PIPN) is a severe and dose‐limiting side effect. This study investigated the therapeutic potential of Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) and its underlying mechanism.
Methods
A murine PIPN model was established. Behavioral tests assessed neuropathic pain. Molecular and cellular analyzes, including western blot, ELISA, and transmission electron microscopy, evaluated oxidative stress, mitochondrial function, and key protein expression in dorsal root ganglia (DRG) and SH‐SY5Y cells. The PGC‐1α inhibitor SR‐18292 was used for mechanistic validation.
Results
High‐dose PACAP (100 μg/kg) significantly alleviated PTX‐induced mechanical allodynia and thermal/cold hyperalgesia. It reduced oxidative stress (lowered ROS/MDA, increased SOD) and restored mitochondrial function (improved membrane potential, ATP, and ultrastructure) in DRG neurons. PACAP upregulated PGC‐1α and HO‐1 expression, and its protective effects were abolished by PGC‐1α inhibition. Crucially, PACAP did not interfere with PTX's antitumor efficacy.
Conclusion
PACAP alleviates PIPN by activating the PGC‐1α pathway to improve mitochondrial function and counteract oxidative stress, presenting a promising adjunct therapy that does not compromise chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
- Department of Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, China.
- Center for Medical Experiments (CME), Shenzhen Guangming District People's Hospital, Shenzhen, China.
- School of Medical Technology, North Minzu University, Yinchuan, China.
ORCID-Profile: Haibei Hu, Wuping Sun
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Shenzhen Nanshan District Healthcare System Science and Technology Key Projects
- Medical-Engineering Interdisciplinary Research Foundation of Shenzhen University
Zitieren
APA
Mo, R., Wang, C., Hu, H., Shi, S., Cao, D., Luo, Z., Yang, H., Zhai, M., & Sun, W. (2026). PACAP Alleviates Paclitaxel‐Induced Peripheral Neuropathy by Targeting Oxidative Stress and Mitochondrial Damage via the PGC‐1α Pathway. CNS Neuroscience & Therapeutics, 32(1). https://doi.org/10.1002/cns.70745
Vancouver
Mo R, Wang C, Hu H, Shi S, Cao D, Luo Z, et al. PACAP Alleviates Paclitaxel‐Induced Peripheral Neuropathy by Targeting Oxidative Stress and Mitochondrial Damage via the PGC‐1α Pathway. CNS Neuroscience & Therapeutics. 2026;32(1). doi:10.1002/cns.70745
BibTeX
@article{Mo2026,
author = {Mo, Ruyue and Wang, Chuanming and Hu, Haibei and Shi, Shuqi and Cao, Di and Luo, Zhenhui and Yang, Hua and Zhai, Mingzhu and Sun, Wuping},
title = {PACAP Alleviates Paclitaxel‐Induced Peripheral Neuropathy by Targeting Oxidative Stress and Mitochondrial Damage via the PGC‐1α Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {1},
doi = {10.1002/cns.70745}
}
EUVIMED